Biotechnology
3Z: Zebrafish mutant model reveals novel drug candidates for ADHD
REYKJAVIK, Iceland, Nov. 22, 2022 /PRNewswire/ -- ADHD is a highly prevalent neurodevelopmental disorder. The first-line therapeutic for ADHD, methylphenidate, is beneficial for only a subset of patients and can cause side effects including weight loss, insomnia and hypertension. Therefore, the ...
2022-11-22 10:54
2667
Better treatments for breast cancer! Latest Clinical Data of Bispecific Antibodies will be presented at SABCS 2022 By Alphamab Oncology
SUZHOU, China, Nov. 22, 2022 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that results from three clinical studies of KN026 (anti-HER2 bispecific antibody) and KN046 (PD-L1/CTLA4 bispecific antibody) will be presented as Spotlight Poster Discussion or Poster Presentation at t...
2022-11-22 09:18
3844
First Patient Dosed in Phase II 'IPAX-Linz' Study of TLX101 for Glioblastoma Therapy
MELBOURNE, Australia, Nov. 22, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that a first patient has been dosed in a Phase II investigator-initiated study of TLX101 in combination with external beam radiation therapy (EBRT) in patients with rec...
2022-11-22 04:59
3021
Umoja Biopharma and IASO Biotherapeutics Announce Research Collaboration to Bring Off-the-Shelf Therapies to Patients with Hematological Malignancies
Collaboration will bring together Umoja's iCIL platform and IASO's chimeric antigen receptors to create the next generation of broadly accessible, readily available cell therapies in indications that are significantly underserved by today's standards of care. SEATTLE, SAN JOSE, Calif., SHANGHAI ...
2022-11-21 21:00
2405
Immorna Receives IND Clearance to Conduct a Phase 1/2 Study of JCXH-221, a Broadly Protective mRNA-Based COVID-19 Vaccine
MORRISVILLE, N.C., Nov. 21, 2022 /PRNewswire/ -- Immorna, a rapidly expanding biotechnology company, focusing on the development of multi-platform RNA-based therapeutics and vaccines, today announced that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) a...
2022-11-21 20:00
1865
Cambrex to Acquire Snapdragon Chemistry, a Leader in Continuous Flow API Development Services
EAST RUTHERFORD, N.J., Nov. 21, 2022 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that it has entered into a definitive agreeme...
2022-11-21 19:00
2466
OLON, INTERNATIONAL API SUPPLIER, RELEASES THE NEW SUSTAINABILITY REPORT 2022 CONFIRMING THE PROGRESS OF ITS SUSTAINABILITY IN THE FOCUS AREAS OF ENVIRONMENT, SUPPLY CHAIN, PEOPLE, COMMUNITY ENGAGEMENT, PRODUCTION
"Our ambition is to promote a more sustainable production of APIs, meeting the highest standards of quality"Paolo Tubertini, CEO of the Group, commented "To achieve this, we are investing in people, in innovation and technology processes, endorsing the sustainable development goals proposed by th...
2022-11-21 18:00
2244
MEDICA 2022 Newcomer: Scivita Medical celebrates trade show success and the strategy of "globalization"
DUSSELDORF, Germany, Nov. 20, 2022 /PRNewswire/ -- Medical technology company Scivita Medical Technology Co., Ltd. ("Scivita Medical") looks back on an exciting week at the trade fair. Scivita Medical was able to announce a strategic cooperation with FUJIFILM Europe B.V. ("Fujifilm") at this year...
2022-11-21 12:00
2827
RVAC MEDICINES AND A*STAR TO BUILD CAPABILITIES FOR mRNA PRODUCTION IN SINGAPORE
SINGAPORE, Nov. 20, 2022 /PRNewswire/ -- RVAC Medicines Pte. Ltd. (RVAC), a messenger RNA (mRNA) technology platform company incubated by CBC Group, a healthcare-dedicated asset management firm headquartered inSingapore, and the Agency for Science, Technology and Research (A*STAR) today announced...
2022-11-21 10:00
2272
Genotek (Yerevan, Armenia), Professor Tamara Sarkisian and Illumina open a world-class genomic laboratory
Yesterday, the genetic laboratory Genotek started to work in Yerevan, Armenia. The main goal is to provide the people of the region with affordable and modern medical technologies and to create new varieties of agricultural plants and animals. YEREVAN, Armenia, Nov. 19, 2022 /PRNewswire/ -- The ...
2022-11-19 03:30
10938
MEDICOX Signs Contract with ORAMED to Distribute Oral Insulin in South Korea
- MEDICOX secures distribution right for ORAMED's oral insulin in South Korea after phase 3 of FDA approval - Contract scale up to 18 million dollars for developmental milestone and up to 15% royalty for sales - ORAMED says 1 in 7 Korean adults over 30 have diabetes and expects market potential ...
2022-11-18 17:11
2470
GenScript takes home Executive of the Year - Biotechnology at the SBR Management Excellence Awards 2022
Mr. Johnson Wang has propelled the GenScript APAC team to achieve numerous milestones despite external challenges. SINGAPORE, Nov. 18, 2022 /PRNewswire/ -- Global biotechnology corporation, GenScript Asia Pacific's President, Mr.Johnson Wang bagged the Executive of the Year - Biotechnology title...
2022-11-18 15:23
5148
Asa Ren and G42 Healthcare Team Up to Advance Genomic Sequencing and Bioinformatics in Indonesia
JAKARTA, Indonesia, Nov. 17, 2022 /PRNewswire/ -- Asa Ren Pte Ltd ("Asa Ren"), a leading consumer DNA data company based inIndonesia, has announced a strategic partnership with leading UAE-based Artificial Intelligence technology company, G42 Health Care AI Holding RSC LTD ("G42 Healthcare"). Th...
2022-11-17 19:49
3193
In operation the most innovative 11.74T MRI Core Magnet to be used on humans
GENOA, Italy, Nov. 17, 2022 /PRNewswire/ -- The world's first simultaneous multi-channel/multi-nuclear 11.74T MRI system is currently under development at Gachon University Gil Medical Center (GUGMC). In the first Half of 2022 GUGMC successfully completed the Site Acceptance Test of the Magne...
2022-11-17 16:25
3164
Standigm Synthetic Research Center successfully accelerates drug discovery in its first year
Lab uniquely enables collaboration between chemical and AI researchers
SEOUL, South Korea, Nov. 16, 2022 /PRNewswire/ -- Standigm
2022-11-17 08:45
2658
RemeGen's Disitamab Vedotin Achieves First-Line Treatment Recommendation Status for Advanced Urothelial Cancer in Updated 2022 CSCO Guidelines
YANTAI, China, Nov. 17, 2022 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a Chinese commercial-stage biotechnology company, announced onNovember 5 that the Company's self-developed novel antibody-drug conjugate (ADC) Disitamab Vedotin (RC48) has been offi...
2022-11-17 08:00
3107
BDT Capital Partners acquires minority stake in Exyte
* Partnership will enhance Exyte's long-term strategy as the world leader in the design, engineering, and delivery of high-tech facilities * Exyte serves clients in the sophisticated markets of semiconductors, battery cells, pharmaceuticals, biotechnology, and data centers; industries offerin...
2022-11-16 21:31
4015
BioVaxys Sarbecovirus Vaccine Interim Data Excellent Emerging Safety & Tolerability Profile with BVX-1021
VANCOUVER, BC, Nov. 16, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is pleased to announce that interim results from its ongoing preclinical of BVX-1021, the Company's vaccine for SARS-CoV-1 ("SARS1") which is being evaluated in a...
2022-11-16 21:00
4273
Imaging Endpoints Announces the Appointment of Joy (Huan) Zhu, M.D., Ph.D., as Vice President, Medical Operations
SCOTTSDALE, Ariz., Nov. 16, 2022 /PRNewswire/ -- Imaging Endpoints (IE), the world's largest oncology-focused imaging CRO, announced today the addition of Joy (Huan) Zhu, M.D., Ph.D., to the company as Vice President, Medical Operations. Prior to joining IE, Joy spent 25 years in oncology clinica...
2022-11-16 21:00
2891
Gracell Biotechnologies Wins 2022 Fierce Life Sciences Innovation Award
FasTCAR next-day manufacturing autologous CAR-T platform recognized with prestigious biotech innovation award SAN DIEGO, Calif. and SUZHOU and SHANGHAI, China, Nov. 16, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharma...
2022-11-16 21:00
3707
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
[Picked up by 298 media titles]
2024-11-26 18:49Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
[Picked up by 294 media titles]
2024-11-26 13:00TAILG's First Flagship Store in Indonesia Grandly Opens
[Picked up by 283 media titles]
2024-11-22 21:59
MediSun Energy Raises $8.75M Seed Round with Vynn Capital to Drive MENA Expansion and Advance Osmotic Energy Innovation
[Picked up by 278 media titles]
2024-11-25 10:00
Most Read
Chinese path to modernization a model for Global South, experts say
2024-11-23 15:35
9907
Innovative technology and applications recognised with Hong Kong ICT Awards 2024
2024-11-23 02:02
6348
SUNLU Formnext 2024 Event Highlights: From Functional Filaments to FilaDryer E2
2024-11-23 21:00
6232
